JP Nadda on Wednesday."India developed two indigenous vaccines for the first time in just nine months, which have been administered to 18 crore Indians so far.
By the end of December, the vaccine will be available to all and its calendar has been set," Nadda was quoted as saying by news agency PTI.India's drug controller has so far given approval to three Covid-19 vaccines -- Covaxin, Covishield and Sputnik V.While Covaxin is indigenously developed by Hyderabad-based manufacturer Bharat Biotech, Covishield uses the Oxford-AstraZeneca formula and is being locally manufactured by the Serum Institute of India.Sputnik V is a Russian vaccine developed by Moscow's Gamaleya Institute.Other responses on Covid situation Nadda's statement came during.